• Citer

Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model.

par Mathieu, Véronique ;Le Mercier, Marie ;De Nève, Nancy;Sauvage, Sébastien ;Gras, Thierry ;Roland, Isabelle ;Lefranc, Florence ;Kiss, Robert
Référence Journal of investigative dermatology, 127, 10, page (2399-2410)
Publication Publié, 2007-10

Article révisé par les pairs

• Détails
• Contenu

Titre:	Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model.
Auteur:	Mathieu, Véronique; Le Mercier, Marie; De Nève, Nancy; Sauvage, Sébastien; Gras, Thierry; Roland, Isabelle; Lefranc, Florence; Kiss, Robert
Informations sur la publication:	Journal of investigative dermatology, 127, 10, page (2399-2410)
Statut de publication:	Publié, 2007-10
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Animals
	Antineoplastic Agents -- therapeutic use
	Antineoplastic Agents, Alkylating -- pharmacology
	Antineoplastic Agents, Alkylating -- therapeutic use
	Apoptosis -- drug effects
	Cathepsin B -- metabolism
	Cell Line, Tumor
	Cisplatin -- therapeutic use
	Dacarbazine -- analogs & derivatives
	Dacarbazine -- pharmacology
	Dacarbazine -- therapeutic use
	Disease Models, Animal
	Female
	Galectin 1 -- genetics
	Galectin 1 -- physiology
	Gene Expression Regulation, Neoplastic -- drug effects
	Gene Expression Regulation, Neoplastic -- physiology
	HSP72 Heat-Shock Proteins -- physiology
	Melanoma -- drug therapy
	Melanoma -- pathology
	Melanoma -- physiopathology
	Mice
	Mice, Knockout
	RNA, Small Interfering -- pharmacology
	Skin Neoplasms -- drug therapy
	Skin Neoplasms -- pathology
	Skin Neoplasms -- physiopathology
	Xenograft Model Antitumor Assays
Note générale:	Comparative Study
	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0022-202X
	info:doi/10.1038/sj.jid.5700869
	info:pii/5700869
	info:scp/34848896271
	info:pmid/17495956